VOR vs. SRRK

Last updated Jun 9, 2026

VOR (Vor Biopharma Inc.) and SRRK (Scholar Rock Holding Corporation) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, VOR returned -49.81%/yr vs 8.97%/yr for SRRK. At a 0.30 correlation, their price movements are largely independent.

Performance

VOR vs. SRRK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vor Biopharma Inc. (VOR) and Scholar Rock Holding Corporation (SRRK). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, VOR achieves a 1.61% return, which is significantly higher than SRRK's -0.57% return.

VOR

• 1D: 0.99%
• 1M: -21.55%
• YTD: 1.61%
• 6M: 58.97%
• 1Y: 196.92%
• 3Y*: -48.97%
• 5Y*: -49.81%
• 10Y*: —

SRRK

• 1D: -1.13%
• 1M: -9.49%
• YTD: -0.57%
• 6M: -3.20%
• 1Y: 27.96%
• 3Y*: 84.27%
• 5Y*: 8.97%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

VOR vs. SRRK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
VOR Vor Biopharma Inc.	1.61%	-41.08%	-50.67%	-66.17%	-42.77%	-69.01%
SRRK Scholar Rock Holding Corporation	-0.57%	1.92%	129.89%	107.73%	-63.57%	-61.58%

Correlation

The correlation between VOR and SRRK is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.22
Correlation (3Y) Calculated over the trailing 3-year period	0.23
Correlation (5Y) Calculated over the trailing 5-year period	0.29
Correlation (All Time) Calculated using the full available price history since Feb 8, 2021	0.30

Fundamentals

Market Cap VOR : $571.62M SRRK : $5.57B
EPS VOR : -$53.66 SRRK : -$3.49
Total Revenue (TTM) VOR : $0.00 SRRK : $0.00
Gross Profit (TTM) VOR : -$23.00K SRRK : -$1.27M
EBITDA (TTM) VOR : -$1.13B SRRK : -$394.71M

Return for Risk

VOR vs. SRRK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VOR

VOR Risk / Return Rank: 79
VOR Sharpe Ratio Rank: 76
VOR Sortino Ratio Rank: 88
VOR Omega Ratio Rank: 85
VOR Calmar Ratio Rank: 78
VOR Martin Ratio Rank: 69

SRRK

SRRK Risk / Return Rank: 59
SRRK Sharpe Ratio Rank: 58
SRRK Sortino Ratio Rank: 61
SRRK Omega Ratio Rank: 57
SRRK Calmar Ratio Rank: 60
SRRK Martin Ratio Rank: 61

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VOR vs. SRRK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vor Biopharma Inc. (VOR) and Scholar Rock Holding Corporation (SRRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	VOR	SRRK	Difference
Sharpe ratio: Return per unit of total volatility	1.15	0.43	+0.73
Sortino ratio: Return per unit of downside risk	2.89	1.20	+1.69
Omega ratio: Gain probability vs. loss probability	1.35	1.14	+0.21
Calmar ratio: Return relative to maximum drawdown	2.27	0.81	+1.47
Martin ratio: Return relative to average drawdown	3.30	1.92	+1.38
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

VOR vs. SRRK - Sharpe Ratio Comparison

The current VOR Sharpe Ratio is 1.15, which is higher than the SRRK Sharpe Ratio of 0.43. The chart below compares the historical Sharpe Ratios of VOR and SRRK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	VOR	SRRK	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.15	0.43	+0.73
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.43	0.05	-0.48
Sharpe Ratio (All Time) Calculated using the full available price history	-0.46	0.09	-0.54

Drawdowns

VOR vs. SRRK - Drawdown Comparison

The maximum VOR drawdown since its inception was -99.72%, which is greater than SRRK's maximum drawdown of -93.15%. Use the drawdown chart below to compare losses from any high point for VOR and SRRK.

Drawdown Indicators

	VOR	SRRK	Difference
Max Drawdown Largest peak-to-trough decline	-99.72%	-93.15%	-6.57%
Max Drawdown (1Y) Largest decline over 1 year	-87.15%	-34.86%	-52.29%
Max Drawdown (3Y) Largest decline over 3 years	-97.07%	-65.21%	-31.86%
Max Drawdown (5Y) Largest decline over 5 years	-99.32%	-88.96%	-10.36%
Current Drawdown Current decline from peak	-98.77%	-35.61%	-63.16%
Average Drawdown Average peak-to-trough decline	-88.72%	-56.44%	-32.28%
Ulcer Index Depth and duration of drawdowns from previous peaks	60.00%	14.61%	+45.39%

Volatility

VOR vs. SRRK - Volatility Comparison

Vor Biopharma Inc. (VOR) has a higher volatility of 22.75% compared to Scholar Rock Holding Corporation (SRRK) at 13.58%. This indicates that VOR's price experiences larger fluctuations and is considered to be riskier than SRRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VOR	SRRK	Difference
Volatility (1M) Calculated over the trailing 1-month period	22.75%	13.58%	+9.17%
Volatility (6M) Calculated over the trailing 6-month period	72.58%	35.86%	+36.72%
Volatility (1Y) Calculated over the trailing 1-year period	171.96%	65.55%	+106.41%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	116.47%	180.23%	-63.76%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	116.80%	157.72%	-40.92%

Dividends

VOR vs. SRRK - Dividend Comparison

Neither VOR nor SRRK has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both VOR and SRRK in my portfolio?

VOR and SRRK have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, VOR or SRRK?

VOR has higher volatility (22.75%) compared to SRRK (13.58%). In terms of maximum drawdown, VOR dropped -99.72% vs SRRK's -93.15%.

Which has better risk-adjusted returns?

VOR currently has the higher Sharpe Ratio (1.15 vs 0.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.